Yarrow Bioscience, Inc.

Initiate Phase 2b portion of Graves' Disease trial

Deadline not yet reached (612 days left)

Announced: 10 Sep 2026
Due: 30 Jun 2028

Deadline
Met
Late
Not met
Today

What the company said

“Initiate Ph 2b portion of GD trial 1H 2028”

SourceYarrow Bioscience, Inc. Form 8-K press release, 2026-09-10
FilingSEC filing index
Deadline as stated1H 2028
Deadline used30 Jun 2028, the last day of the stated period
TypeProject
Permanent referenceKI-C-2026-YARW-000612
Cite as https://keptindex.org/c/KI-C-2026-YARW-000612/ — this address never changes.

What we found

The deadline has not passed yet, so there is nothing to check. We look for evidence starting 30 days after 30 Jun 2028.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Clinical milestone
Indicative materiality: Medium rules
Action: Initiate

Tell me what happens

This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.

Alert me when this resolves

How this entry was checked

Commitment recordedRecorded from the company's filing.
OutcomeNot yet assessed. Nothing is judged before the deadline.

Are you Yarrow Bioscience, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2026-YARW-000612 · Corrections policy